Hyderabad: Aurobindo Pharma Ltd has approved a proposal to file a Scheme of Amalgamation before the National Company Law Tribunal (NCLT), Hyderabad, for the merger of its two step-down wholly owned subsidiaries, Eugia Steriles Private Limited and Eugia SEZ Private Limited, with Eugia Pharma Specialities Limited, a wholly owned subsidiary of the company. The proposal has been approved by the Boards of Directors of the respective companies as well as Aurobindo Pharma. Eugia Pharma reported a turnover of ₹27,259.04 million, Eugia Steriles recorded ₹62.7 million, while Eugia SEZ posted a turnover of ₹4,874.2 million. The company clarified that no cash consideration or share exchange ratio is involved, as the merger is between wholly owned subsidiaries. It further stated that Aurobindo Pharma is not a party to the Scheme of Amalgamation and that the proposed transaction will not result in any change in the shareholding pattern of the listed entity.